Lucy Liu - School of Pharmacy, Fudan University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis

Kun Wang, Yusong Zhu,Fengyan Xu,Lucy Liu, Lichuan Liu, Mengling Shi, Jing Nie,Harald Reinhart, Jing Liu,Yuying Gao, Xia Pu

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024): 106713-106713

引用0浏览0WOS引用

Clinical Dose Rationale of Tislelizumab in Patients with Solid or Hematological Advanced Tumors

Tian Yu, Xiangyu Liu,Chi-Yuan Wu,Zhiyu Tang, Hongwei Wang,Patrick Schnell, Ya Wan,Kun Wang,Lucy Liu,Yuying Gao,Srikumar Sahasranaman,Nageshwar Budha

CTS-CLINICAL AND TRANSLATIONAL SCIENCE（2024）

引用0浏览0WOS引用

Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model

Yawen Yuan,Zhihong Li,Ke Wang,Shunguo Zhang,Qingfeng He,Lucy Liu,Zhijia Tang,Xiao Zhu,Ying Chen,Weimin Cai,Chao Peng,Xiaoqiang Xiang

Molecules/Molecules online/Molecules annual（2023）

引用0浏览0WOS引用

Model‐based Population Pharmacokinetic Analysis of Tislelizumab in Patients with Advanced Tumors

Nageshwar Budha,Chi-Yuan Wu,Zhiyu Tang, Tian Yu,Lucy Liu,Fengyan Xu,Yuying Gao, Ruiying Li, Qiuyang Zhang, Ya Wan,Srikumar Sahasranaman

CPT pharmacometrics & systems pharmacology（2022）

引用3浏览0WOS引用

Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling

Size Li,Yiqun Yu,Xiaolan Bian,Li Yao,Min Li,Yan-Ru Lou,Jing Yuan,Hai-shu Lin,Lucy Liu,Bing Han,Xiaoqiang Xiang

ARCHIVES OF TOXICOLOGY（2021）

引用53浏览0WOS引用

Rationale for once-daily or twice-daily dosing of zanubrutinib in patients with mantle cell lymphoma

Ying C Ou,Zhiyu Tang,William Novotny,Aileen Cohen,Kun Wang,Lucy Liu,Yuying Gao,Srikumar Sahasranaman

LEUKEMIA & LYMPHOMA（2021）

引用16浏览0WOS引用

Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials

Hong Xiang,Lucy Liu,Yuying Gao,Ago Ahene,Helen Collins

Cancer Chemother Pharmacol（2021）

引用2浏览0WOS引用

Population Pharmacokinetic Analysis of the BTK Inhibitor Zanubrutinib in Healthy Volunteers and Patients With B-Cell Malignancies

Ying C Ou,Lucy Liu,Bilal Tariq,Kun Wang,Ashutosh Jindal,Zhiyu Tang,Yuying Gao,Srikumar Sahasranaman

Clinical and translational scienceno. 2 (2021): 764-772

引用10浏览0WOS引用

Population Pharmacokinetic Analysis of Phase 1 Bemarituzumab Data to Support Phase 2 Gastroesophageal Adenocarcinoma FIGHT Trial

Xiang Hong,Liu Lucy,Gao Yuying,Ahene Ago, TRex Bio, Inc., Merck and Co.,Dreiling Lyndah,Collins Helen

Cancer chemotherapy and pharmacology（2020）

引用18浏览0WOS引用

Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicity

Ugur Eskiocak,Wilson Guzman,Benjamin Wolf, Christine Cummings,Lauren Milling,Hsin-Jung Wu,Michael Ophir,Conner Lambden,Pearl Bakhru, Dana C. Gilmore,Samantha Ottinger,Lucy Liu, William K. McConaughy, Sunny Q. He,Chao Wang,Cheuk Lun Leung,Jason Lajoie, William F. Carson, Nora Zizlsperger,Michael M. Schmidt,Ana C. Anderson,Piotr Bobrowicz,Thomas J. Schuetz,Robert Tighe

JCI INSIGHT（2020）

引用31浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn